Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 28.05.2026
Highlight Communications AG
PRESS RELEASE
The Highlight Group publishes results for first quarter of 2026
Consolidated sales amounted to CHF 63.9 million (previous year: CHF 79.9 million), primarily due to production-related and foreign currency effects.
EBIT improved significantly by CHF 10.9 million to CHF -6.1 million (previous year: CHF -17.0 million).
EBITDA improve [ … ]
Thu, 28.05.2026
Haier Biomedical
QINGDAO, China, May 28, 2026 /PRNewswire/ -- Haier Biomedical (SHA: 688139) has been named the No. 1 Chinese brand in global life science laboratory equipment sales and No. 1 in overseas sales in the same category, according to 2025 data published by Euromonitor International. The dual ranking places Haier Biomedical at the front of a competitive g [ … ]
Thu, 28.05.2026
The Stepstone Group
EQS-Media / 28.05.2026 / 15:05 CET/CEST
Press releaseSebastian Dettmers to hand over CEO role at Stepstone after 15 years: Christian Schmalzl appointed successor
Dr. Sebastian Dettmers to step down as CEO of The Stepstone Group after 15 years with the company and more than six years at its helm
Christian Schmalzl, previously Co-CEO of Ströer, [ … ]
Thu, 28.05.2026
Diginex Limited
Diginex Subsidiary Matter More Than Triples Carbon Data Automation to 80%; Breakthrough Accelerates ESG Insights for Institutions Overseeing $20 Trillion in Assets
State-of-the-art AI + human architecture: the new extraction pipeline tripled automation from 25% to 80%, supported by multi-stage quality control.
Scale: Matter is releasing carbon [ … ]
Thu, 28.05.2026
Avalara, Inc.
Planned leadership transition positions Avalara to accelerate and scale its AI-driven innovation
DURHAM, N.C., May 28, 2026 /PRNewswire/ -- Avalara, Inc., the agentic AI leader in global tax and compliance, announced that Hugo Sarrazin has been appointed Chief Executive Officer. Scott McFarlane, Avalara's co-founder and original CEO, will become an [ … ]
Thu, 28.05.2026
Northwest Biotherapeutics Inc.
Company Name:
Northwest Biotherapeutics Inc.
ISIN:
US66737P6007
Reason for the research:
Update
Recommendation:
BUY
from:
28.05.2026
Target price:
USD 1.00
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research has published a research update on Northwest Biotherapeuti [ … ]
Thu, 28.05.2026
aiMotive
Joint proof-of-concept demonstrates a real-world-to-simulation pipeline that transforms vehicle fleet data into high-fidelity synthetic environments – indistinguishable from real-world sensor data – validating SVNet perception outputs in real time on cloud infrastructure.
SEOUL, South Korea and BUDAPEST, Hungary, May 28, 2026 /PRNewswire/ -- STRADV [ … ]
Thu, 28.05.2026
Kling AI
EQS Newswire / 28/05/2026 / 13:15 CET/CEST
CANNES, FRANCE - Media OutReach Newswire - 28 May 2026 - A shift is underway in the global film industry as creators across the globe embrace Kling AI to produce cinematic-level visuals and push the boundaries of storytelling. Native 4K Generation for Cinematic-Level Output "For House of David, we d [ … ]
Thu, 28.05.2026
KION GROUP AG
20 years of KION – connecting the heritage with the future at the Annual General Meeting 2026
Three new members of KION GROUP AG’s Supervisory Board elected
Supervisory Board and Executive Board proposals approved with majority vote
Dividend of € 0.62 per share to be paid out
Contract of Michael Larsson, President KION IAS and ITS Americas, ext [ … ]
Thu, 28.05.2026
Immunic AG
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
– Late-Breaking Poster Introduces New Unified Statistical Analyses for Assessing Confirmed Disability Changes for Trials in Progressive Multiple Sclerosis –
– Additional C [ … ]
